Guanwei Fan | Cardiovascular research | Best Researcher Award

Posted on by ScienceFather

Prof. Guanwei Fan | Cardiovascular research | Best Researcher Award

Prof. Guanwei Fan, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, China

Prof. Guanwei Fan, PhD, is a prominent researcher at the First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, China. His research focuses on the molecular pharmacology of traditional Chinese medicine in cardiovascular diseases. Prof. Fan has received numerous accolades, including recognition as a national “WR” scientific and technological innovation talent and ranking among the top 2% of scientists globally in recent years. He has published extensively, contributing significantly to the understanding of cardiac repair and treatment methodologies. With a strong commitment to advancing traditional medicine, he continues to impact the field profoundly. πŸ“šβ€οΈ

 

Publication Profile

Scopus

Education

Prof. Guanwei Fan obtained his Doctoral degree from Tianjin University of Traditional Chinese Medicine (09/2005-06/2008) after earning his Master’s degree from the same institution (09/2002-07/2005). His academic background provides a solid foundation for his research endeavors in traditional Chinese medicine.

Research Direction

Prof. Fan specializes in the molecular pharmacology of traditional Chinese medicine, specifically in the context of cardiovascular diseases. His focus on this area demonstrates his commitment to bridging traditional practices with modern scientific methodologies, contributing valuable insights to the field of pharmacology.

Academic and Professional Achievements

Prof. Fan has garnered significant recognition for his contributions to research and innovation. He has been selected as a national “WR” scientific and technological innovation leading talent and enjoys special government subsidies from The State Council. He is also a national candidate for the Millions of Talents Project and has been recognized as a young and middle-aged scientific and technological innovation leading talent by the Ministry of Science and Technology. Additionally, he holds the title of the first Young Qihuang Scholar and has received multiple accolades, including Tianjin Outstanding Youth and Jinmen Medical Talents. Notably, he ranked among the top 2% of the world’s top scientists in the “Impact of 2022” and “Impact of 2021” lists.

Conclusion

Prof. Guanwei Fan is a highly suitable candidate for the Research for Best Researcher Award. His innovative approach to integrating traditional Chinese medicine with modern pharmacological research in cardiovascular diseases sets him apart as a leading figure in his field.

 

Publication Top Notes Β 

  • Zhang, K., Yin, Z., Chen, F., … Wang, Y., Fan, G. Omics-based pharmacological evaluation reveals Yuanhu Zhitong oral liquid ameliorates arthritis by regulating PKC/ERK/NF-ΞΊB signaling pathway. Journal of Ethnopharmacology, 2024. πŸ“–
  • Liu, Z., Bian, X., Li, L., … Liu, X., Fan, G. SENP1-Mediated HSP90ab1 DeSUMOylation in Cardiomyocytes Prevents Myocardial Fibrosis by Paracrine Signaling. Advanced Science, 2024. πŸ“–
  • Lin, J., Chen, Y., Luo, X., Fan, G. Research hotspots and trends of traditional Chinese and western medicine in treatment of heart failure with preserved ejection fraction. Chinese Traditional and Herbal Drugs, 2024. πŸ“–
  • Feng, C., Jiang, H., Fan, G., Li, L., Feng, J. Retrospective Study on the Efficacy of Qi Li Qiang Xin Jiao Nang in Reducing the Risk of Diuretic Resistance in Patients with Acute Decompensated Chronic Heart Failure. Chinese General Practice, 2024. πŸ“–
  • Shi, J., Yang, M.M., Yang, S., … Fan, G., Ma, C. MaiJiTong granule attenuates atherosclerosis by reducing ferroptosis via activating STAT6-mediated inhibition of DMT1 and SOCS1/p53 pathways in LDLRβˆ’/βˆ’ mice. Phytomedicine, 2024. πŸ“–
  • Li, Z., Lyu, C., Pan, G., … Zhang, B., Huang, Y., Fan, G. Strategies and methods for studying interaction between traditional Chinese and western medicine dominated by clinical benefit-risk signals. Chinese Traditional and Herbal Drugs, 2024. πŸ“–
  • Zhang, K., Ji, J., Li, N., Yin, Z., Fan, G. Integrated Metabolomics and Gut Microbiome Analysis Reveals the Efficacy of a Phytochemical Constituent in the Management of Ulcerative Colitis. Molecular Nutrition and Food Research, 2024. πŸ“–
  • Zhao, Y., Zheng, G., Yang, S., … Fan, G., Ma, C. The plant extract PNS mitigates atherosclerosis via promoting Nrf2-mediated inhibition of ferroptosis through reducing USP2-mediated Keap1 deubiquitination. British Journal of Pharmacology, 2024. πŸ“–
  • Wu, L.-L., Yang, B.-R., Meng, X.-Y., Fan, G.-W., Yang, B. Editorial: Artificial intelligence: new hope for critically ill cardiovascular patients. Frontiers in Medicine, 2024. πŸ“–
  • Zhang, L., Lin, J., Zhang, C., … Fan, G., He, F. Recent Advances in the Nanotechnology-Based Applications of Essential Oils. Current Nanoscience, 2024. πŸ“–

 

 

 

Xiangxiang Zheng | Cardiovascular Medicine | Best Researcher Award

Posted on by ScienceFather

Dr. Xiangxiang Zheng | Cardiovascular Medicine | Best Researcher Award

Dr. Xiangxiang Zheng, Jiangsu Province Hospital, China

Dr. Xiangxiang Zheng, a dedicated cardiac surgeon at Jiangsu Provincial People’s Hospital since 2008, specializes in minimally invasive treatments for heart valve diseases and stem cell therapy for myocardial infarction. With a PhD and over 300 cardiac surgeries performed annually, he is at the forefront of cardiovascular innovation. His notable publications include research on engineering extracellular vesicles for diagnosis and therapy, and comparing surgical techniques for atrial septal defect repair. Dr. Zheng’s work significantly contributes to advancing surgical practices and improving patient outcomes. He is 42 years old and married. β€οΈπŸ‘¨β€βš•οΈπŸ“š

 

Publication profile

Scopus


Professional Experience

Since 2008, Dr. Xiangxiang Zheng has been an esteemed cardiac surgeon in the Department of Cardiovascular Surgery at Jiangsu Provincial People’s Hospital. With over 300 cardiac surgeries performed annually, he has established himself as a leader in the field. Dr. Zheng specializes in minimally invasive treatments for heart valve diseases, which significantly reduce recovery time and improve patient outcomes. His expertise also extends to stem cell therapy for myocardial infarction, where he employs innovative techniques to enhance heart repair and regeneration. Dr. Zheng’s dedication to advancing cardiovascular care is evident through his hands-on surgical practice and commitment to exploring new methodologies in cardiac surgery. He continuously strives to improve surgical techniques and patient safety, making a lasting impact on the lives of those he treats. His contributions not only elevate the standard of care in his department but also serve as an inspiration to his colleagues and the medical community. πŸŒŸπŸ‘¨β€βš•οΈπŸ“ˆ

 

Research Focus

Dr. Xiangxiang Zheng’s research primarily focuses on cardiovascular surgery, particularly in innovative surgical techniques and therapies for heart diseases. His work emphasizes minimally invasive procedures, such as thoracoscopic surgeries for atrial septal defect repair, as well as advanced myocardial protection strategies during complex cardiac surgeries. Additionally, Dr. Zheng explores stem cell therapy and the engineering of extracellular vesicles for therapeutic applications, enhancing diagnosis and treatment methods in cardiology. His research also delves into the physiological impacts of surgical interventions on heart function and the progression of pulmonary arterial hypertension, contributing significantly to the field of cardiovascular medicine. πŸ₯πŸ“šβœ¨

 

Publication Top Notes

  • Engineering extracellular vesicles for diagnosis and therapy 🧬
    Fei, Z., Zheng, J., Zheng, X., Ren, H., Liu, G.
    Trends in Pharmacological Sciences, 2024.
    Cited by: 0
  • The Impact of Highly Selective Thoracic Sympathectomy on the Progression of Monocrotaline-induced Pulmonary Arterial Hypertension in Rats 🐭
    Liu, W., Men, C., Liu, Z., Zhang, L., Zheng, X.
    Journal of Physiological Investigation, 2024, 67(4), pp. 207-214.
    Cited by: 0
  • Triport Periareolar Thoracoscopic Surgery versus Right Minithoracotomy for Repairing Atrial Septal Defect in Adults πŸ’”
    Zheng, X.-X., Wang, Z.-Y., Ma, L.-Y., Qin, J.-W., Shao, Y.-F.
    Interactive Cardiovascular and Thoracic Surgery, 2021, 32(2), pp. 313-318.
    Cited by: 5
  • Comparison of Myocardial Protection Effect between Del Nido Cardioplegia and Cold Blood Cardioplegia in Complex Cardiac Surgery πŸ’‰
    Jiao, S.-Y., Liu, L., Ma, L.-Y., Zheng, X.-X., Qin, J.-W.
    Chinese Journal of Clinical Research, 2020, 33(6), pp. 807-810.
    Cited by: 0
  • Myocardial Protective Effect of Three Cardioplegia in Adult Valve Replacement πŸ’—
    Liu, H., Jiao, S.-Y., Ma, L.-Y., Zheng, X.-X., Qin, J.-W.
    Chinese Journal of Clinical Research, 2019, 32(6), pp. 775-778.
    Cited by: 1
  • Bilateral Superior Cervical Ganglionectomy Attenuates the Progression of Ξ²-Aminopropionitrile-induced Aortic Dissection in Rats πŸ§ͺ
    Liu, H., Zheng, X., Zhang, L., Shao, Y., Zhang, S.
    Life Sciences, 2018, 193, pp. 200-206.
    Cited by: 5
  • Cardiac Autotransplantation for Repair of Left Ventricular Rupture after Mitral Valve Replacement πŸ₯
    Ni, B., Zheng, X., Zhang, S., Shao, Y.
    Interactive Cardiovascular and Thoracic Surgery, 2017, 25(1), pp. 150-152.
    Cited by: 3
  • Three Circulating LncRNA Predict Early Progress of Esophageal Squamous Cell Carcinoma πŸ”¬
    Hu, H.-B., Jie, H.-Y., Zheng, X.-X.
    Cellular Physiology and Biochemistry, 2016, 40(1-2), pp. 117-125.
    Cited by: 68
  • High Expression of LncRNA PVT1 Promotes Invasion by Inducing Epithelial-to-Mesenchymal Transition in Esophageal Cancer πŸš€
    Zheng, X., Hu, H., Li, S.
    Oncology Letters, 2016, 12(4), pp. 2357-2362.
    Cited by: 85
  • Myxoid Fibrosarcoma of the Left Atrium and Ventricle in Pregnancy πŸ‘Άβ€οΈ
    Zhang, W., Zheng, X., Ni, B., Shao, Y., Zhang, S.
    Annals of Thoracic Surgery, 2014, 98(5), pp. 1818-1819.
    Cited by: 3

Shuo Sha | Hypertension | Best Researcher Award

Posted on by ScienceFather

Dr. Shuo Sha | Hypertension | Best Researcher Award

Dr. Shuo Sha, The First Hospital of Shanxi Medical University, China

Dr. Sha Shuo is a dedicated PhD candidate at Shanxi Medical University, specializing in Internal Medicine. She began her academic journey in August 2023 and is expected to graduate by June 2027. With a commitment to full-time study, Dr. Sha exemplifies perseverance and academic excellence in her pursuit of higher education. Her research focuses on advancing knowledge in the field of Internal Medicine, aiming to contribute significantly to healthcare innovation. πŸŽ“

 

Publication profile

Scopus

πŸŽ“ Education

Sha Shuo is currently pursuing her PhD in Internal Medicine at Shanxi Medical University. She joined the graduate school in August 2023 under a full-time format and is expected to graduate by June 2027.

Research Focus

Dr. Sha Shuo’s research focuses on energy-efficient automatic train operation for high-speed railways, with a particular emphasis on discrete notches and neutral sections. She investigates how these elements impact overall energy consumption and operational efficiency. By studying these factors, Dr. Sha aims to optimize train performance and energy usage, contributing to sustainable transportation solutions πŸš„. Her work integrates theoretical models with practical applications, aiming to enhance the reliability and environmental sustainability of high-speed rail networks through innovative operational strategies and technological advancements in railway systems.

 

Publication Top Notes

Energy-efficient automatic train operation for high-speed railways: Considering discrete notches and neutral sections